Valuation Valneva SE London S.E.

Stocks

Market Closed - London S.E. Other stock markets 03:03:24 2026-05-14 EDT			5-day change	1st Jan Change
2.592 ^EUR	-38.30%		+15.92%	-30.05%

06-29	Certain Ordinary Shares of Valneva SE are subject to a Lock-Up Agreement Ending on 30-JUN-2026.	CI
06-26	European Medicines Agency Panel Recommends Change to Valneva's Chikungunya Vaccine Marketing Approval	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,574	861.1	655.1	351.1	642.3	408.9	-	-
Change	-	-66.55%	-23.93%	-46.4%	82.94%	-36.34%	-	-
Enterprise Value (EV) ¹	2,286	670.5	737.8	399.1	739.9	536.9	468.9	460.3
Change	-	-70.66%	10.04%	-45.9%	85.38%	-27.44%	-12.66%	-1.83%
P/E	-32.7x	-5.02x	-6.47x	-27x	-5.47x	-5.87x	5.67x	7.33x
PBR	15.1x	-	5.1x	1.94x	6.07x	7.18x	3.13x	2.24x
PEG	-	-0.1x	0.2x	0.3x	-0x	0.1x	-0x	-0.3x
Capitalization / Revenue	7.4x	2.38x	4.26x	2.07x	3.68x	2.69x	1.39x	1.63x
EV / Revenue	6.57x	1.86x	4.8x	2.35x	4.24x	3.54x	1.59x	1.83x
EV / EBITDA	-48.5x	-9.69x	-11.3x	12.1x	-12.5x	-16.7x	4.54x	8.69x
EV / EBIT	-37.2x	-5.91x	-8.99x	29.9x	-9.12x	-9.9x	5.49x	8.21x
EV / FCF	-140x	-2.44x	-3.4x	-4.92x	-12.9x	-8.7x	5.11x	60.3x
FCF Yield	-0.71%	-41%	-29.4%	-20.3%	-7.75%	-11.5%	19.6%	1.66%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.75	-1.24	-0.73	-0.08	-0.68	-0.3671	0.38	0.294
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	348.1	361.3	153.7	169.6	174.7	151.8	294	250.9
EBITDA ¹	-47.1	-69.2	-65.24	32.92	-59.42	-32.23	103.3	53
EBIT ¹	-61.4	-113.4	-82.09	13.33	-81.16	-54.21	85.44	56.08
Net income ¹	-73.4	-143.3	-101.4	-12.25	-115.2	-66.01	70.5	38.87
Net Debt ¹	-288.9	-190.6	82.74	48.04	97.6	128	60.02	51.46
Reference price ²	24.500	6.224	4.720	2.162	3.718	2.156	2.156	2.156
Nbr of stocks (in thousands)	105,078	138,355	138,788	162,397	172,759	189,647	-	-
Announcement Date	2/3/22	3/23/23	3/21/24	3/20/25	3/17/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
REVOLUTION MEDICINES, INC.	-23.34x	351.51x	-21.46x	-.--%	39.58B
BEONE MEDICINES AG	46.99x	4.73x	30.33x	-.--%	34.69B
IQVIA HOLDINGS INC.	25.1x	2.78x	12.03x	-.--%	34.42B
CELLTRION, INC.	27.15x	7.96x	19.98x	0.42%	27.11B
MEDPACE HOLDINGS, INC.	31.75x	5.12x	23.3x	-.--%	15.36B
EUROFINS SCIENTIFIC SE	24.41x	2.07x	9.09x	1.1%	14.05B
ICON PUBLIC LIMITED COMPANY	24.03x	1.91x	11.58x	-.--%	13.02B
ABIVAX	-32.61x	124.59x	-35.46x	-.--%	11.76B
Average	15.44x	62.58x	6.17x	0.19%	23.75B
Weighted average by Cap.	16.14x	84.13x	7.25x	0.14%